醫療器械股逆市受捧 華潤醫療(01515.HK)、春立(01858.HK)及復銳(01696.HK)漲逾8%-14%
恆指及科指由今天由約半年高位回吐0.3%及0.4%,現報21,320及4,550。然而,多隻醫療股逆市受捧,尤其是復銳醫療科技(01696.HK)繼昨天稍為抖氣後,今天再發力,午後股價曾高見13.14元創半年高,現報12.9元,急漲14%,成交額增至2,993萬元。
春立醫療(01858.HK)連續兩天創逾一年高,最高見19.42元,現報19.18元,續升9.4%,成交額續增至6,548萬元。華潤醫療(01515.HK)兩連升兼突破上月所創52周高位6.08元,最高見6.59元,創近16個月高,現報6.46元,續漲8.4%,成交額急增至5,846萬元。貝康醫療-B(02170.HK)續升7.7%報4.18元。坤博醫療-B(02216.HK)回升9.3%曾高見2.43元。
微創醫療(00853.HK)反覆高見23.4元,創半年高,現報22.2元,續升4%,成交額增至近2.5億元。心通醫療-B(02160.HK)高見3.11元,創四個月高,現報3.04元,續升3.4%,成交額增至3,523萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.